Citation Formats
Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

N. Ermis Et Al. , "Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.," Biotechnic & histochemistry : official publication of the Biological Stain Commission , pp.1-10, 2023

Ermis, N. Et Al. 2023. Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.. Biotechnic & histochemistry : official publication of the Biological Stain Commission , 1-10.

Ermis, N., Ulutas, Z., Ozhan, O., Yildiz, A., Vardi, N., Colak, C., ... Parlakpinar, H.(2023). Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.. Biotechnic & histochemistry : official publication of the Biological Stain Commission , 1-10.

Ermis, Necip Et Al. "Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.," Biotechnic & histochemistry : official publication of the Biological Stain Commission , 1-10, 2023

Ermis, Necip Et Al. "Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.." Biotechnic & histochemistry : official publication of the Biological Stain Commission , pp.1-10, 2023

Ermis, N. Et Al. (2023) . "Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.." Biotechnic & histochemistry : official publication of the Biological Stain Commission , pp.1-10.

@article{article, author={Necip Ermis Et Al. }, title={Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.}, journal={Biotechnic & histochemistry : official publication of the Biological Stain Commission}, year=2023, pages={1-10} }